MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
INO Cash Flow Sankey Diagram
Sankey diagram visualizing INO cash flow for the period
Proceeds from issuance of
warrants, net of issuance...
$13,963,956
Proceeds from issuance of
common stock, net of...
$3,247,068
(194.61%↑ Y/Y)
Proceeds from sale of
investments
$4,152,141
(-59.56%↓ Y/Y)
Proceeds from maturity of
investments
$1,000,000
Purchases of investments
-$994,539
(-120.11%↓ Y/Y)
Net cash provided by
financing activities
$17,155,061
(1627.33%↑ Y/Y)
Net cash provided by
investing activities
$6,146,680
(17.52%↑ Y/Y)
Canceled cashflow
$55,963
Decrease in cash and cash
equivalents
$5,254,514
(112.67%↑ Y/Y)
Canceled cashflow
$18,047,227
Taxes paid related to
net share...
-$55,963
(48.66%↑ Y/Y)
Accounts payable and
accrued expenses,...
$2,385,747
(259.28%↑ Y/Y)
Non-cash stock-based
compensation
$768,437
(-65.60%↓ Y/Y)
Loss on sales of
short-term investments
-$573,444
(19.00%↑ Y/Y)
Amortization of operating
lease right-of-use...
$443,852
(-41.41%↓ Y/Y)
Depreciation
$322,034
(-55.74%↓ Y/Y)
Other assets
-$95,406
(-390.68%↓ Y/Y)
Net cash used in
operating activities
-$18,047,227
(62.15%↑ Y/Y)
Canceled cashflow
$4,588,920
Change in fair value of
common stock warrant...
-$13,868,616
Net loss
-$6,012,458
Prepaid expenses and
other current assets,...
$1,480,884
(-17.26%↓ Y/Y)
Operating lease
right-of-use assets and...
-$693,066
(42.58%↑ Y/Y)
Accrued clinical trial
expenses
-$478,870
(6.26%↑ Y/Y)
Net unrealized gain
on...
$94,221
Amortization of discounts on
investments
$8,032
(-38.23%↓ Y/Y)
Back
Back
INOVIO PHARMACEUTICALS, INC. (INO)
INOVIO PHARMACEUTICALS, INC. (INO)
Cash Flow
Quarterly Cash Flow Statement for the quarter ending in 2026-06-30
source: myfinsight.com